Skip to main content
PTCT
NASDAQ Life Sciences

PTC Therapeutics Raises 2026 Guidance After Q2 Revenue Hits $361M, Sephience Sales Surge

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$77.87
Mkt Cap
$6.264B
52W Low
$43.175
52W High
$90.87
52W Position info
80% above low
Off High info
14% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PTCT sits 80% above its 52-week low of $43.175.

Summary

PTC Therapeutics delivered a strong Q2 with total revenue of $361 million, including $239 million in product revenue, driven by Sephience's $151 million (up 21% sequentially). The company raised full-year 2026 total revenue guidance to $1.18-$1.28 billion and product revenue guidance to $850-$950 million, signaling confidence in the ongoing launch. A $50 million milestone from Novartis for the INVEST-HD Phase 3 study added to the top line. The cash position stands at $2.2 billion, providing ample runway. Pipeline progress includes naming PTC303 for Huntington's and myotonic dystrophy, initiating a Phase 1 for PTC612, and planning a Phase 2a for PTC844. This follows the $550 million convertible notes offering completed in June, which strengthened the balance sheet.

At the time of this announcement, PTCT was trading at $77.87 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $43.18 to $90.87. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

PTCT - Latest Insights

PTCT
Nov 03, 2026, 7:00 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $61.39
Real-time Price: $56.41 info
Change: -$4.98 (-8%) info
Market Cap: $4.719B info
PTCT
Oct 29, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $62.00
Real-time Price: $56.41 info
Change: -$5.59 (-9%) info
Market Cap: $4.719B info
PTCT
Oct 29, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $60.00
Real-time Price: $56.41 info
Change: -$3.59 (-6%) info
Market Cap: $4.719B info
PTCT
Oct 29, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $64.57
Real-time Price: $56.41 info
Change: -$8.16 (-13%) info
Market Cap: $4.719B info
PTCT
Aug 28, 2026, 5:42 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $70.09
Real-time Price: $56.41 info
Change: -$13.68 (-20%) info
Market Cap: $4.719B info